Company intelligence / Profile preview

Zynex

Englewood, Colorado, United Statesen.wikipedia.org ↗

Ownership: Public · ZYXI
Employees: ~750
Development stage: Commercial

Overview

Zynex’s flagship product line includes FDA-cleared non-invasive electrotherapy devices for pain management and rehabilitation. The NexWave device combines IFC, TENS, and NMES modalities in a single prescription-only unit. The company also develops neurological diagnostic and non-invasive cardiac monitoring products that are in various stages of development. Their commercialized products have established a strong presence in the U.S. market as alternatives to opioid-based pain management.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: Device (specifically electrotherapy devices such as TENS/IFC/NMES units)Non-pharmacological therapy
Industry: Therapeutic Medical Devices

Financials

Market cap: $3.8M
Total revenue: $13.4M
Enterprise value: $62.2M

Beyond the preview

Go deeper on Zynex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zynex.

Explore the full profile